Alcon and RxSight, Inc. announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs).
Under the collaboration, the companies will be innovating on...
Tenpoint Therapeutics, Ltd. announced that YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is now available in the U.S. for the treatment of presbyopia...
Tenpoint Therapeutics, Ltd. announced that the U.S. Food and Drug Administration (FDA) approved YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as...
LENZ Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) approved VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only FDA-approved aceclidine-based eye...
By Sophia Visanji, OD
The millennial generation is rapidly reaching a milestone no one really enjoys: presbyopia. The growing role of technology in our lives...
HOYA has launched its VisuPro All Day and VisuPro Flex advanced focus spectacle lenses to help young presbyopes, people in their late 30s to mid-40s...